Ferriprox (deferiprone) is a small molecule pharmaceutical. Deferiprone was first approved as Ferriprox on 1999-08-25. It is used to treat iron overload in the USA. It has been approved in Europe to treat beta-thalassemia and iron overload. Ferriprox's patents are valid until 2038-10-25 (FDA).
|Indication||beta-thalassemia, iron overload|